OMB Likely Will Pledge 2005 User Fee Funds; Dec. 3 Is Round Two For MDMA
This article was originally published in The Gray Sheet
Executive Summary
A third-party audit of FDA review costs and workload data associated with the Medical Device User Fee & Modernization Act may be in the offing
You may also be interested in...
OMB’s FY 2005 Device Funding Request Leaves Industry Wary Of FDA Estimate
Legislative changes to the compensating adjustment factor affecting device user fee rates in fiscal 2005 and beyond could be accomplished if Congress revisits the MDUFMA "triggers" in 2004
OMB’s FY 2005 Device Funding Request Leaves Industry Wary Of FDA Estimate
Legislative changes to the compensating adjustment factor affecting device user fee rates in fiscal 2005 and beyond could be accomplished if Congress revisits the MDUFMA "triggers" in 2004
PMA Slowdown To Persist In ’04, McClellan Says; User Fee Hikes To Follow?
FDA expects the rate of new product applications to continue declining for the foreseeable future, despite a series of review cycle improvement initiatives begun in January